Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives.

Area of Science:

• Genetics
• Molecular Biology
• Biotechnology

Background:

• Monogenic disorders result from single-gene mutations, with many lacking effective treatments.
• Current therapies offer limited relief for the majority of these genetic diseases.
• Gene therapy presents a promising therapeutic avenue for monogenic disorders.

Purpose of the Study:

• To review current plasmid-based gene therapy techniques for monogenic diseases.
• To identify and discuss the challenges associated with these gene therapy approaches.
• To explore potential strategies for overcoming existing barriers in gene therapy.

Main Methods:

• Review of existing literature on plasmid-based gene therapy.
• Analysis of current delivery systems and their limitations.
• Identification of challenges including delivery efficiency, expression, immunogenicity, toxicity, and specificity.

Main Results:

• Plasmid-based gene therapy is a key approach for monogenic disorders.
• Significant challenges impede current gene therapy efficacy, including delivery, sustained expression, and safety.
• Various strategies are being developed to address these limitations.

Conclusions:

• Plasmid-based gene therapy holds potential for treating monogenic disorders.
• Overcoming challenges in delivery, expression, and safety is crucial for clinical success.
• Further research into advanced techniques and delivery systems is warranted.